These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 28334154)

  • 1. Ethical issues of CRISPR technology and gene editing through the lens of solidarity.
    Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R;
    Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Editing: Editors Cautionary.
    Krishan K; Kanchan T; Singh B; Baryah N; Puri S
    Clin Ter; 2018; 169(2):e58-e59. PubMed ID: 29595865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New gene editing technique CRISPR-Cas9 raises important ethical questions, says advisory body.
    Hawkes N
    BMJ; 2016 Sep; 354():i5318. PubMed ID: 27694221
    [No Abstract]   [Full Text] [Related]  

  • 6. Justice in CRISPR/Cas9 Research and Clinical Applications.
    Hildebrandt CC; Marron JM
    AMA J Ethics; 2018 Sep; 20(9):E826-833. PubMed ID: 30242813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
    Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
    Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Mediated Gene Editing: Scientific and Ethical Issues.
    Bailey J
    Trends Biotechnol; 2019 Sep; 37(9):920-921. PubMed ID: 31182244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered CRISPR Systems for Next Generation Gene Therapies.
    Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
    ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR.
    Benston S
    J Med Ethics; 2017 Dec; 43(12):819-823. PubMed ID: 28473627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.